0.38Open0.38Pre Close0 Volume15 Open Interest25.00Strike Price0.00Turnover155.34%IV70.45%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.38Extrinsic Value100Contract SizeAmericanOptions Type0.1445Delta0.0375Gamma39.18Leverage Ratio-0.0276Theta0.0012Rho5.66Eff Leverage0.0089Vega
Quanterix Stock Discussion
ABOS PEPG TOPS AAPL DIS XPEV MNMD TSM QTRX
$Acumen Pharmaceuticals(ABOS.US)$ $PepGen(PEPG.US)$ $Top Ships(TOPS.US)$ $Apple(AAPL.US)$ $Disney(DIS.US)$ $XPeng(XPEV.US)$ $Mind Medicine(MNMD.US)$ $Taiwan Semiconductor(TSM.US)$ $Quanterix(QTRX.US)$
In reaction to earnings/guidance:
• $GoodRx(GDRX.US)$ +38.5%, $EDGIO(EGIO.US)$ +13.5%, $Lemonade(LMND.US)$ +10.7%, $Desktop Metal(DM.US)$ +8.5%, $ShockWave Medical(SWAV.US)$ +8.2%, $Pubmatic(PUBM.US)$ +8.1%, $Olaplex(OLPX.US)$ +7%, $Vivid Seats(SEAT.US)$ +6.4%, $Noble(NE.US)$ +6.3%, $Aspen Technology(AZPN.US)$ +5.4%, $AAON Inc(AAON.US)$ +5%, $Hudbay Minerals(HBM.US)$ +5%, $Vivint Smart Home(VVNT.US)$ +4.9%, $Vivint Smart Home(VVNT.US)$ +4...
• $MillerKnoll(MLKN.US)$ +12.4%, $BioNTech(BNTX.US)$ +7.4%, $Lululemon Athletica(LULU.US)$ +6.5% (also authorizes $1 bln stock repurchase program)
• $Adagio Therapeutics(ADGI.US)$ +52.47% (announces ADG20 (adintrevimab) is the first monoclonal antibody to meet primary endpoints with statistical significance across pre- and post-exposure prophylaxis and treatment for COVID-19 and plans to seek US emergency use authorization)
...
No comment yet